Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Kim, Kwang Hyun ^a   You, Dalsan ^a   Jeong, In Gab ^a   Kwon, Tae Won ^a   Cho, Yong Mee ^a   Hong, Jun Hyuk ^a   Ahn, Hanjong ^a   Kim, Choung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Inferior vena cava; Nephrectomy; Renal cell carcinoma; Thrombosis

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CAVA VEIN DISEASE; CLINICAL FEATURE; FEMALE; HISTOLOGY; HUMAN; INFERIOR VENA CAVA THROMBUS; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEPHRECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; THROMBECTOMY; THROMBUS; TYPE 2 PAPILLARY HISTOLOGY; AGED; COMPARATIVE STUDY; FOLLOW UP; INFERIOR CAVA VEIN; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SOUTH KOREA; SURVIVAL RATE; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBECTOMY; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

MLCS; MLOWN;

EID: 84876450984     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11498.x     Document Type: Article

References (36)

1. Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 1991; 145: 20-3
2. Marshall FF, Dietrick DD, Baumgartner WA, Reitz BA. Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins. J Urol 1988; 139: 1166-72
3. Haferkamp A, Bastian PJ, Jakobi H et al. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term follow-up. J Urol 2007; 177: 1703-8
4. Klatte T, Pantuck AJ, Riggs SB et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 2007; 178: 1189-95
5. Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007; 69: 1054-8
6. Wagner B, Patard JJ, Mejean A et al. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 2009; 55: 452-9
7. Martinez-Salamanca JI, Huang WC, Millan I et al. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol 2011; 59: 120-7
8. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004; 94: 33-41
9. Ciancio G, Manoharan M, Katkoori D, De Los Santos R, Soloway MS. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience. Eur Urol 2010; 57: 667-72
10. Klaver S, Joniau S, Suy R, Oyen R, Van Poppel H. Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b). BJU Int 2008; 101: 444-9
11. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 2008; 112: 1480-8
12. Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 1976; 38: 2469-80
13. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-24
14. Leibovich BC, Lohse CM, Crispen PL et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010; 183: 1309-15
15. Teloken PE, Thompson RH, Tickoo SK et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 2009; 182: 2132-6
16. Patard JJ, Leray E, Rioux-Leclercq N et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23: 2763-71
17. Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987; 59: 390-5
18. Kwon TW, Kim H, Moon KM et al. Surgical treatment of inferior vena cava tumor thrombus in patients with renal cell carcinoma. J Korean Med Sci 2010; 25: 104-9
19. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-4
20. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006; 49: 798-805
21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63
22. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. M od Pathol 1997; 10: 537-44
23. Rabbani F, Hakimian P, Reuter VE, Simmons R, Russo P. Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology. J Urol 2004; 171: 1057-61
24. Herrmann E, Trojan L, Becker F et al. Prognostic factors of papillary renal cell carcinoma: results from a multiinstitutional series after pathological review. J Urol 2010; 183: 460-6
25. Pignot G, Elie C, Conquy S et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007; 69: 230-5
26. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM .Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001; 32: 590-5
27. Mejean A, Hopirtean V, Bazin JP et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 2003; 170: 764-7
28. Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. V irchows Arch 2003; 4 42: 336-42
29. Ficarra V, Martignoni G, Galfano A et al. Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol 2006; 50: 786-93
30. Karakiewicz PI, Briganti A, Chun FK et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 2007; 2 5: 1316-22
31. Waldert M, Haitel A, Marberger M et al. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. BJU Int 2008; 102: 1381-4
32. Ronnen EA, Kondagunta GV, Ishill N et al. Treatment outcome for metastatic papillary renal cell carcinoma patients. Cancer 2006; 107: 2617-21
33. Kassouf W, Sanchez-Ortiz R, Tamboli P et al. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol 2007; 178: 1896 - 900
34. Gore ME, Szczylik C, Porta C et al. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial. L ancet Oncol 2009; 10: 757-63
35. Dutcher JP, de Souza P, McDermott D et al. Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Med Oncol 2009; 26: 202-9
36. Bertini R, Roscigno M, Freschi M et al. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. Eur Urol 2011; 60: 358-65